Rainbow Childrens Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the Regulation 30 of the SEBI Listing Regulations, please find attached copies of newspaper advertisement of Financial Results of the Company for the quarter and financial year ended on March 31, 2022, published in Financial Express and Surya on May 29, 2022. We request you to kindly take the same on record. Rainbow Childrens Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached the invite of the Conference Call for Investors/ Analysts to be held on Monday, May 30, 2022 at 10:30 A.M IST to discuss the financial and operating performance for Q4 & FY22. We request you to kindly take the same on record. Rainbow Childrens Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith the Press Release for the Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022. Rainbow Childrens Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), please find attached herewith Earnings Presentation of the Company on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022, which the Company proposes to share with analysts/ investors. We request you to please take the same on record. Rainbow Childrens Medicare Ltd - 543524 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 27, 2022
Dear Sir/ Madam, Please take note that the Board of Directors in their meeting held today i.e. May 27, 2022 approved following matters: 1. The Audited Standalone and Consolidated Financial Results ("Results") of the Company for the Quarter and Financial Year ended March 31, 2022. A copy of the signed Results along with Auditors Report and Declaration in respect of Audit Report with unmodified opinion under Regulation 33 of the Listing Regulations is attached herewith. 2. Recommendation of final dividend of INR. 2.0/- per Equity Share (@ 20% on a face value of INR. 10/- per share) for the Financial Year ended March 31, 2022. The dividend, if approved by the shareholders at the ensuing Annual General Meeting ('AGM') will be dispatched/ credited within 30 days of the AGM and further information in this regard including record date etc. shall be submitted with the Stock Exchanges in due course. Rainbow Childrens Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Dividend Updates
Please take note that the Board of Directors in their meeting held today i.e. May 27, 2022 Recommended final dividend of INR. 2.0/- per Equity Share (@ 20% on a face value of INR. 10/- per share) for the Financial Year ended March 31, 2022. The dividend, if approved by the shareholders at the ensuing Annual General Meeting ('AGM') will be dispatched/ credited within 30 days of the AGM and further information in this regard including record date etc. shall be submitted with the Stock Exchanges in due course. Rainbow Childrens Medicare Ltd - 543524 - Financial Results For The Quarter & Financial Year Ended March 31, 2022
Please take note that the Board of Directors in their meeting held today i.e. May 27, 2022 approved following matters: 1. The Audited Standalone and Consolidated Financial Results ("Results") of the Company for the Quarter and Financial Year ended March 31, 2022. A copy of the signed Results along with Auditors Report and Declaration in respect of Audit Report with unmodified opinion under Regulation 33 of the Listing Regulations is attached herewith. 2. Recommendation of final dividend of INR. 2.0/- per Equity Share (@ 20% on a face value of INR. 10/- per share) for the Financial Year ended March 31, 2022. The dividend, if approved by the shareholders at the ensuing Annual General Meeting ('AGM') will be dispatched/ credited within 30 days of the AGM and further information in this regard including record date etc. shall be submitted with the Stock Exchanges in due course. Rainbow Childrens Medicare Ltd - 543524 - Board Meeting Intimation for Consideration And Approval , Inter-Alia , The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31, 2022 And To Consider Recommending Final Dividend.
Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 ,inter alia, to consider and approve the Audited (Standalone & Consolidated) Financial results of the Company for the Quarter and Financial Year ended March 31, 2022 and to consider recommending Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended March 31, 2022. We request you to kindly take the same on record. Rainbow Childrens Medicare Ltd - 543524 - Closure of Trading Window
We wish to inform you that as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's code for Prevention of Insider Trading, the Trading Window, has been closed from May 10, 2022 and would be re-opened after 48 hours of date of announcement / declaration of Audited Financial Results for the Quarter and Financial Year ending March 31, 2022.